In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Cecilia Caetano, vice president, global medical ...

Shah Capital has ended its attempts to exert influence over vaccine developer Novavax, bringing more than years of activism ...

The immunology alliance follows a collaboration between the UK Biobank and the University of Exeter, supported by the Novo ...

Swiss biotech Nouscom has closed a €120 million ($135 million) fourth-round financing for a vaccine to protect people with a ...

The EMA's human medicines committee, the CHMP, has recommended approval of Eli Lilly's oral GLP-1 agonist Foundayo for weight management and treatment of type 2 diabetes (T2D). The decision puts ...

GSK is preparing to cut more than 1,200 positions from its workforce in Belgium as part of a cost-saving programme launched by CEO Luke Miels, according to national newspaper L'Echo. The article notes ...

On paper, the programme was built. In practice, many never crossed the finish line. Demand was not the problem. In a June ...

Shares in Neurocrine Bioscience took a tumble after the company reported mid-stage data for a key pipeline drug for schizophrenia that failed to impress investors. The 19% after-market selloff came ...

Pharmaceutical supply chains have more data at their fingertips than ever before. The challenge is turning that information into foresight. From temperature monitoring devices and connected containers ...

Although real progress has been made in managing depression over recent decades, significant hurdles remain. In fact, around ...